Skip to main content
TipRanks
Go Ultimate75% OFF

PW Medtech Group Ltd. (PWE) AI Stock Analysis

0 Followers
DE:PWE

PW Medtech Group Ltd.

(Frankfurt:PWE)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Very Low LeverageThe exceptionally low debt burden gives PW Medtech substantial financial flexibility and reduces exposure to interest costs or refinancing pressure. This conservative structure can help the company sustain operations, invest selectively, and absorb weaker trading conditions over the next several quarters.
Negative Factors
Revenue and Margin DecelerationThe simultaneous contraction in revenue and profitability is a meaningful deterioration in operating momentum. Lower sales and weaker margins can reduce earnings power, limit reinvestment capacity, and make it harder for the company to sustain its earlier growth trajectory over coming quarters.

PW Medtech Group Ltd. (PWE) vs. iShares MSCI Germany ETF (EWG)

-50%-40%-30%-20%-10%0%10%20%DE:PWE-35.07%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 148.51M
Dividend Yield
3.40%
Average Volume (3M)
150
Price to Earnings (P/E)
26.8
Beta (1Y)
0.20
Revenue Growth
-8.58%
EPS Growth
-70.97%
Country
Germany
Employees
1,433
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

PW Medtech Group Ltd. Business Overview & Revenue Model

Company Description

Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medic...

PW Medtech Group Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:PWE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:3600HK:360080OutperformHKD 6.72B9.8620.11%4.02%12.50%44.44%
HK:6929HK:692978OutperformHKD 3.05B8.7210.50%5.45%16.25%7.80%
HK:1066HK:106673OutperformHKD 14.97B9.315.64%5.13%7.47%-26.89%
HK:6699HK:669966NeutralHKD 13.96B40.698.95%1.17%――
HK:1501HK:150159NeutralHKD 6.34B21.219.64%0.88%34.94%12.99%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%DE:PWEHK:1066HK:3600HK:1501HK:6699HK:6929Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:PWE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:PWEPW Medtech Group Ltd.0.09-0.05-35.07%
HK:1066Shandong Weigao Group Medical Polymer Co Class H3.29-1.95-37.20%
HK:3600Modern Dental Group Limited7.202.2344.99%
HK:1501Shanghai Kindly Medical Instruments Co., Ltd. Class H29.42-0.24-0.83%
HK:6699Angelalign Technology Inc.79.4019.4032.32%
HK:6929OrbusNeich Medical Group Holdings Limited3.67-0.43-10.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.